search
Back to results

Intraoperative Protective Ventilation in Abdominal Surgery (IMPROVE Study)

Primary Purpose

Protective Lung Ventilation Using:, Low Tidal Volume (6-8 mL/kg Predicted Body Weight), PEEP of 6-8 cmH2O

Status
Completed
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
Abdominal surgery
Sponsored by
University Hospital, Clermont-Ferrand
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Protective Lung Ventilation Using: focused on measuring Mechanical ventilation, Postoperative pulmonary complications, Positive end-expiratory pressure, Protective lung ventilation, Alveolar recruitment maneuver, General anesthesia, Abdominal surgery

Eligibility Criteria

40 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Planned intrabdominal surgery
  • Expected duration ≥ 2 hours
  • Age ≥ 40 yr (and <90 yr)
  • Risk of postoperative pulmonary complications (Arozullah score ≥2)

Exclusion Criteria:

  • Noninvasive ventilation in the last 30 days
  • Recent history of pneumonia, ALI/ARDS (in the last 30 days)
  • History of pulmonary resection
  • History of neuromuscular disease
  • Patient refusal

Sites / Locations

  • Chu Clermont-Ferrand

Outcomes

Primary Outcome Measures

Composite endpoint defined as incidence of major postoperative pulmonary (defined as pneumonia, need for noninvasive ventilation or need for invasive ventilation) and extrapulmonary (SIRS, sepsis and septic shock) complications

Secondary Outcome Measures

Major complications: postoperative hypoxemia, postoperative pneumonia, acute lung injury (ALI), acute respiratory distress syndrome (ARDS), pulmonary embolism
Minor complications : atelectasis, anastomotic leakage, intrabdominal abscess
Other postoperative complications (reintervention, wound abscess, ...)
Systemic level of marker of inflammation (C Reactive protein)
Postoperative complications at day 30 after surgery
Need for ICU admission
ICU length of stay
Hospital length of stay
Mortality
Plasma levels of the soluble form of the receptor for advanced glycation end-products (sRAGE), a marker of alveolar type I cell injury

Full Information

First Posted
January 18, 2011
Last Updated
October 4, 2012
Sponsor
University Hospital, Clermont-Ferrand
search

1. Study Identification

Unique Protocol Identification Number
NCT01282996
Brief Title
Intraoperative Protective Ventilation in Abdominal Surgery (IMPROVE Study)
Official Title
Intraoperative Lung Protective Ventilation in Abdominal Surgery: A Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2012
Overall Recruitment Status
Completed
Study Start Date
January 2011 (undefined)
Primary Completion Date
August 2012 (Actual)
Study Completion Date
August 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to compare the influence of a lung protective ventilation with conventional ventilation on postoperative complications following major abdominal surgery.
Detailed Description
Postoperative complications are associated with a significant and quantifiable rate of both morbidity and mortality, increased length of hospital stay and cost of care. Intra-abdominal surgery, especially upper abdominal surgery, is an important risk factor of both pulmonary and extra-pulmonary complications. Up to 15-20% of patients will develop postoperative respiratory failure which may require respiratory support. Recent data from both experimental and clinical studies suggested that, compared with conventional ventilation using high tidal volume (TV) without positive end-expiratory pressure (PEEP), intraoperative lung protective ventilation using low tidal volume, PEEP and recruitment maneuvers (RM) could reduce postoperative complications. Conventional ventilation promotes sustained cytokine production and could therefore contribute to development of lung injury with in patients with normal lungs. Conversely, lung protective ventilation was found to reduce pulmonary and systemic inflammation. The primary objective is to compare a lung protective ventilation with conventional ventilation (high tidal volumes without PEEP) during abdominal surgery: 1- Conventional ventilation with TV of 10-12 mL/kg predicted body weight (PBW) without PEEP; 2- Protective lung ventilation with TV of 6-8 mL/kg PBW, PEEP of 6-8 cmH2O and RM. Our hypothesis is that lung protective ventilation could reduce postoperative pulmonary and extra-pulmonary complications compared with conventional ventilation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Protective Lung Ventilation Using:, Low Tidal Volume (6-8 mL/kg Predicted Body Weight), PEEP of 6-8 cmH2O, Intraoperative RMs
Keywords
Mechanical ventilation, Postoperative pulmonary complications, Positive end-expiratory pressure, Protective lung ventilation, Alveolar recruitment maneuver, General anesthesia, Abdominal surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
400 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Other
Intervention Name(s)
Abdominal surgery
Intervention Description
to compare the influence of a lung protective ventilation with conventional ventilation on postoperative complications following major abdominal surgery
Primary Outcome Measure Information:
Title
Composite endpoint defined as incidence of major postoperative pulmonary (defined as pneumonia, need for noninvasive ventilation or need for invasive ventilation) and extrapulmonary (SIRS, sepsis and septic shock) complications
Time Frame
during the first seven days after surgery
Secondary Outcome Measure Information:
Title
Major complications: postoperative hypoxemia, postoperative pneumonia, acute lung injury (ALI), acute respiratory distress syndrome (ARDS), pulmonary embolism
Time Frame
at day 15 after surgery
Title
Minor complications : atelectasis, anastomotic leakage, intrabdominal abscess
Time Frame
at day 15 after surgery
Title
Other postoperative complications (reintervention, wound abscess, ...)
Time Frame
at day 15 after surgery
Title
Systemic level of marker of inflammation (C Reactive protein)
Time Frame
at day 15 after surgery
Title
Postoperative complications at day 30 after surgery
Time Frame
at day 30 after surgery
Title
Need for ICU admission
Time Frame
at day 30 after surgery
Title
ICU length of stay
Time Frame
at day 30 after surgery
Title
Hospital length of stay
Time Frame
at day 30 after surgery
Title
Mortality
Time Frame
at day 30 after surgery
Title
Plasma levels of the soluble form of the receptor for advanced glycation end-products (sRAGE), a marker of alveolar type I cell injury
Time Frame
before surgery, during the immediate postoperative period and on day 1, day 3 and day 7 after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Planned intrabdominal surgery Expected duration ≥ 2 hours Age ≥ 40 yr (and <90 yr) Risk of postoperative pulmonary complications (Arozullah score ≥2) Exclusion Criteria: Noninvasive ventilation in the last 30 days Recent history of pneumonia, ALI/ARDS (in the last 30 days) History of pulmonary resection History of neuromuscular disease Patient refusal
Facility Information:
Facility Name
Chu Clermont-Ferrand
City
Clermont-Ferrand
ZIP/Postal Code
63003
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
26716865
Citation
Neuschwander A, Futier E, Jaber S, Pereira B, Eurin M, Marret E, Szymkewicz O, Beaussier M, Paugam-Burtz C. The effects of intraoperative lung protective ventilation with positive end-expiratory pressure on blood loss during hepatic resection surgery: A secondary analysis of data from a published randomised control trial (IMPROVE). Eur J Anaesthesiol. 2016 Apr;33(4):292-8. doi: 10.1097/EJA.0000000000000390.
Results Reference
derived
PubMed Identifier
23902482
Citation
Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, Marret E, Beaussier M, Gutton C, Lefrant JY, Allaouchiche B, Verzilli D, Leone M, De Jong A, Bazin JE, Pereira B, Jaber S; IMPROVE Study Group. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013 Aug 1;369(5):428-37. doi: 10.1056/NEJMoa1301082.
Results Reference
derived

Learn more about this trial

Intraoperative Protective Ventilation in Abdominal Surgery (IMPROVE Study)

We'll reach out to this number within 24 hrs